These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26335372)

  • 1. Enhanced Human Epidermal Growth Factor Receptor 2 Degradation in Breast Cancer Cells by Lysosome-Targeting Gold Nanoconstructs.
    Lee H; Dam DH; Ha JW; Yue J; Odom TW
    ACS Nano; 2015 Oct; 9(10):9859-67. PubMed ID: 26335372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells.
    Shen Y; Zhang J; Hao W; Wang T; Liu J; Xie Y; Xu S; Liu H
    Int J Nanomedicine; 2018; 13():537-553. PubMed ID: 29416334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Intelligent DNA Nanorobot with
    Ma W; Zhan Y; Zhang Y; Shao X; Xie X; Mao C; Cui W; Li Q; Shi J; Li J; Fan C; Lin Y
    Nano Lett; 2019 Jul; 19(7):4505-4517. PubMed ID: 31185573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved in vitro efficacy of gold nanoconstructs by increased loading of G-quadruplex aptamer.
    Dam DH; Lee RC; Odom TW
    Nano Lett; 2014 May; 14(5):2843-8. PubMed ID: 24689438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-Functionalized Gold Nanostars for on-Demand Delivery of Anticancer Therapeutics.
    Wu D; Zhao P; Wu L; Lin L; Yu G; Xu L; Yue J
    ACS Appl Bio Mater; 2020 Jul; 3(7):4590-4599. PubMed ID: 35025458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types.
    Dam DH; Culver KS; Odom TW
    Mol Pharm; 2014 Feb; 11(2):580-7. PubMed ID: 24422969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lapatinib-incorporated lipoprotein-like nanoparticles: preparation and a proposed breast cancer-targeting mechanism.
    Zhang L; Zhang S; Ruan SB; Zhang QY; He Q; Gao HL
    Acta Pharmacol Sin; 2014 Jun; 35(6):846-52. PubMed ID: 24902791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth.
    Mahlknecht G; Maron R; Mancini M; Schechter B; Sela M; Yarden Y
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8170-5. PubMed ID: 23630281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres.
    Florczak A; Mackiewicz A; Dams-Kozlowska H
    Int J Nanomedicine; 2019; 14():6855-6865. PubMed ID: 32021156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of HER2-Specific Aptamer-Drug Conjugate for Breast Cancer Therapy.
    Jeong HY; Kim H; Lee M; Hong J; Lee JH; Kim J; Choi MJ; Park YS; Kim SC
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer.
    Zhang C; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
    Sci Rep; 2020 Dec; 10(1):22015. PubMed ID: 33328545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIR-cleavable drug adducts of gold nanostars for overcoming multidrug-resistant tumors.
    Del Valle AC; Su CK; Sun YC; Huang YF
    Biomater Sci; 2020 Mar; 8(7):1934-1950. PubMed ID: 32039412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting HER2+ breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles.
    Owen SC; Patel N; Logie J; Pan G; Persson H; Moffat J; Sidhu SS; Shoichet MS
    J Control Release; 2013 Dec; 172(2):395-404. PubMed ID: 23880472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells.
    Saleh T; Soudi T; Shojaosadati SA
    Int J Biol Macromol; 2019 Jun; 130():109-116. PubMed ID: 30802519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars.
    Dam DH; Culver KS; Kandela I; Lee RC; Chandra K; Lee H; Mantis C; Ugolkov A; Mazar AP; Odom TW
    Nanomedicine; 2015 Apr; 11(3):671-9. PubMed ID: 25461281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cascaded Aptamers-Governed Multistage Drug-Delivery System Based on Biodegradable Envelope-Type Nanovehicle for Targeted Therapy of HER2-Overexpressing Breast Cancer.
    Liang T; Yao Z; Ding J; Min Q; Jiang L; Zhu JJ
    ACS Appl Mater Interfaces; 2018 Oct; 10(40):34050-34059. PubMed ID: 30207689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle Anisotropy Increases Targeting Interactions on Live-Cell Membranes.
    Diloknawarit B; Lee K; Choo P; Odom TW
    ACS Nano; 2024 May; 18(19):12537-12546. PubMed ID: 38684051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2+ breast cancer.
    Wang Y; Chen J; Irudayaraj J
    ACS Nano; 2011 Dec; 5(12):9718-25. PubMed ID: 22053819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer CaCO3 nanostructures: a facile, pH-responsive, specific platform for targeted anticancer theranostics.
    Zhou C; Chen T; Wu C; Zhu G; Qiu L; Cui C; Hou W; Tan W
    Chem Asian J; 2015 Jan; 10(1):166-71. PubMed ID: 25377905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer targeting with biomolecules: a comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles.
    Obaid G; Chambrier I; Cook MJ; Russell DA
    Photochem Photobiol Sci; 2015 Apr; 14(4):737-47. PubMed ID: 25604735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.